Brexucabtagene autoleucel Alternatives Compared
Brexucabtagene autoleucel | Jaypirca (pirtobrutinib) | Revlimid (lenalidomide) |
|
---|
Brexucabtagene autoleucel | Jaypirca (pirtobrutinib) | Revlimid (lenalidomide) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Acute Lymphoblastic Leukemia, Mantle Cell Lymphoma. Brexucabtagene autoleucel may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia. Jaypirca may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Anemia, Follicular Lymphoma, Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Multiple Myeloma, Myelodysplastic Diseases. Revlimid may also be used for purposes not listed in... View more |
Related suggestions Mantle Cell Lymphoma
|
|||||||||||||||
More about Brexucabtagene autoleucel | More about Jaypirca (pirtobrutinib) | More about Revlimid (lenalidomide) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Be the first to share your experience with this drug. |
Jaypirca has an average rating of 8.8 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
Revlimid has an average rating of 7.1 out of 10 from a total of 30 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 17% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
View all Jaypirca side effects |
View all Revlimid side effects |
|||||||||||||||||
Drug Class | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Jaypirca prices |
View all Revlimid prices |
||||||||||||||||
Dosage Forms | ||||||||||||||||||
N/A |
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Tecartus |
N/A |
N/A |
||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
N/A |
19 hours |
3 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 308 drugs are known to interact with Brexucabtagene autoleucel:
|
A total of 735 drugs are known to interact with Jaypirca:
|
A total of 279 drugs are known to interact with Revlimid:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
N/A |
January 27, 2023 |
December 27, 2005 |
||||||||||||||||
WADA Class View classifications | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient Resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.